clinical trial transparency
See the following -
Big Pharma Companies Open Up Cancer Trial Comparator Arm Data
A lot has changed in clinical trial transparency since Project Data Sphere outlined plans to share cancer results in 2012, with the European law voted in last week then still a distant threat. Even so, Pfizer ($PFE), Sanofi ($SNY) and the other groups behind the initiative think it still offers something different now that it has belatedly launched.
- Login to post comments
ClinGenuity Uses Artificial Intelligence Redaction Tool To Keep Big Pharma Compliant
ClinGenuity, the Cincinnati medical writing company with the pharmaceutical industry's first and only artificially-intelligent automated redaction management tool, has processed more than a half billion redactions for big pharma companies to help them meet the growing industry demand for pharmaceutical clinical trial disclosure and transparency initiatives...
- Login to post comments
Data Sharing, EHR Interoperability Keys To Improving Clinical Trials
As the complexity of clinical trials continues to grow, increased data sharing and interoperability will become more important, according to panelists participating at a House Energy and Commerce Committee hearing Wednesday...
- Login to post comments
2014 Bio-IT World Conference & Expo
The 2014 Bio-IT World Conference & Expo plans to unite 2,500+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. The Expo provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2014 program will feature compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development, including best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals.
- Login to post comments